Found: 12
Select item for more details and to access through your institution.
Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 6, p. 1, doi. 10.15252/emmm.202114045
- By:
- Publication type:
- Article
Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 6, p. 1, doi. 10.15252/emmm.201810092
- By:
- Publication type:
- Article
Label-Free and High-Throughput Removal of Residual Undifferentiated Cells From iPSC-Derived Spinal Cord Progenitor Cells.
- Published in:
- Stem Cells Translational Medicine, 2024, v. 13, n. 4, p. 387, doi. 10.1093/stcltm/szae002
- By:
- Publication type:
- Article
Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.710217
- By:
- Publication type:
- Article
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00879
- By:
- Publication type:
- Article
Modulating neuroinflammation through molecular, cellular and biomaterial‐based approaches to treat spinal cord injury.
- Published in:
- Bioengineering & Translational Medicine, 2023, v. 8, n. 2, p. 1, doi. 10.1002/btm2.10389
- By:
- Publication type:
- Article
Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
- Published in:
- Journal of Clinical Immunology, 2022, v. 42, n. 2, p. 214, doi. 10.1007/s10875-021-01142-z
- By:
- Publication type:
- Article
Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 2, p. 1, doi. 10.1002/cti2.1241
- By:
- Publication type:
- Article
Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody response.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 4, p. 1, doi. 10.1002/cti2.1126
- By:
- Publication type:
- Article
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-19080-6
- By:
- Publication type:
- Article
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16638-2
- By:
- Publication type:
- Article